Advanced search
Publication Cover
mAbs Volume 9, 2017 - Issue 6
Submit an article Journal homepage
2,117
Views
20
CrossRef citations to date
0
Altmetric
Report

Chemically-defined camelid antibody bioconjugate for the magnetic resonance imaging of Alzheimer's disease

Matthias VandesquilleInstitut Pasteur, Unité de Chimie des Biomolécules, Département Biologie Structurale et Chimie, Paris, France; CNRS UMR 3523, Paris, France;French Alternative Energies and Atomic Energy Commission, Institute of Biomedical Imaging, Molecular Imaging Research Center, Fontenay-aux-Roses, France
,
Tengfei LiInstitut Pasteur, CITECH, Plateforme d'Ingénierie des Anticorps, Paris, France;Sorbonne Universités, UPMC Univ. Paris 06 UMR S 1127, and Inserm, U 1127, and CNRS UMR 7225, and ICM, Paris, France;Université Paris Diderot-Paris 7, Paris, France
,
Chrystelle PoInstitut Pasteur, Unité de Chimie des Biomolécules, Département Biologie Structurale et Chimie, Paris, France; CNRS UMR 3523, Paris, France;French Alternative Energies and Atomic Energy Commission, Institute of Biomedical Imaging, Molecular Imaging Research Center, Fontenay-aux-Roses, France
,
Christelle GanneauInstitut Pasteur, Unité de Chimie des Biomolécules, Département Biologie Structurale et Chimie, Paris, France; CNRS UMR 3523, Paris, France
,
Pascal LenormandInstitut Pasteur, CITECH, Plateforme d'Ingénierie des Anticorps, Paris, France
,
Clémence DudeffantSorbonne Universités, UPMC Univ. Paris 06 UMR S 1127, and Inserm, U 1127, and CNRS UMR 7225, and ICM, Paris, France
,
Christian CzechF. Hoffmann-La Roche AG, Pharmaceutical Research and Early Development, NORD DTA, Roche Innovation Center Basel, Basel, Switzerland
,
Fiona GrueningerF. Hoffmann-La Roche AG, Pharmaceutical Research and Early Development, NORD DTA, Roche Innovation Center Basel, Basel, Switzerland
,
Charles DuyckaertsSorbonne Universités, UPMC Univ. Paris 06 UMR S 1127, and Inserm, U 1127, and CNRS UMR 7225, and ICM, Paris, France
,
Benoît DelatourSorbonne Universités, UPMC Univ. Paris 06 UMR S 1127, and Inserm, U 1127, and CNRS UMR 7225, and ICM, Paris, France
,
Marc DhenainFrench Alternative Energies and Atomic Energy Commission, Institute of Biomedical Imaging, Molecular Imaging Research Center, Fontenay-aux-Roses, FranceORCID Iconhttp://orcid.org/0000-0001-8804-4101
ORCID Icon,
Pierre LafayeInstitut Pasteur, CITECH, Plateforme d'Ingénierie des Anticorps, Paris, France
&
Sylvie BayInstitut Pasteur, Unité de Chimie des Biomolécules, Département Biologie Structurale et Chimie, Paris, France; CNRS UMR 3523, Paris, FranceCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3538-2163
ORCID Icon show all
Pages 1016-1027 | Received 14 Feb 2017, Accepted 12 Jun 2017, Published online: 31 Jul 2017

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Xuhong Zhao, Qian Ning, Zhongcheng Mo & Shengsong Tang. (2019) A promising cancer diagnosis and treatment strategy: targeted cancer therapy and imaging based on antibody fragment. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 3621-3630.
Read now

Articles from other publishers (19)

Alena Nikiforova & Igor Sedov. (2023) Molecular Design of Magnetic Resonance Imaging Agents Binding to Amyloid Deposits. International Journal of Molecular Sciences 24:13, pages 11152.
Crossref
Qimeng Li, Ákos Nemecz, Gabriel Aymé, Gabrielle Dejean de la Bâtie, Marie S. Prevost, Stéphanie Pons, Nathalie Barilone, Rayen Baachaoui, Uwe Maskos, Pierre Lafaye & Pierre-Jean Corringer. (2023) Generation of nanobodies acting as silent and positive allosteric modulators of the α7 nicotinic acetylcholine receptor. Cellular and Molecular Life Sciences 80:6.
Crossref
Frédéric Lerouge, Elodie Ong, Hugo Rositi, Francis Mpambani, Lise-Prune Berner, Radu Bolbos, Cécile Olivier, Françoise Peyrin, Vinu K Apputukan, Cyrille Monnereau, Chantal Andraud, Frederic Chaput, Yves Berthezène, Bettina Braun, Mathias Jucker, Andreas KO Åslund, Sofie Nyström, Per Hammarström, K Peter R Nilsson, Mikael Lindgren, Marlène Wiart, Fabien Chauveau & Stephane Parola. (2022) In vivo targeting and multimodal imaging of cerebral amyloid-β aggregates using hybrid GdF 3 nanoparticles . Nanomedicine 17:29, pages 2173-2187.
Crossref
Fang Zheng, Yucheng Pang, Luyao Li, Yuxing Pang, Jiaxin Zhang, Xinyi Wang & Geert Raes. (2022) Applications of nanobodies in brain diseases. Frontiers in Immunology 13.
Crossref
Jean-François Morfin, Sara Lacerda, Carlos F. G. C. Geraldes & Éva Tóth. (2022) Metal complexes for the visualisation of amyloid peptides. Sensors & Diagnostics 1:4, pages 627-647.
Crossref
Parisa Shamshiripour, Fahimeh Hajiahmadi, Shahla Lotfi, Niloofar Robab Esmaeili, Amir Zare, Mahzad Akbarpour & Davoud Ahmadvand. (2022) Next-Generation Anti-Angiogenic Therapies as a Future Prospect for Glioma Immunotherapy; From Bench to Bedside. Frontiers in Immunology 13.
Crossref
Bingxuan Li, Xiaohong Qin & Li-Zhi Mi. (2022) Nanobodies: from structure to applications in non-injectable and bispecific biotherapeutic development. Nanoscale 14:19, pages 7110-7122.
Crossref
Isabelle Landrieu, Elian Dupré, Davy Sinnaeve, Léa El Hajjar & Caroline Smet-Nocca. (2022) Deciphering the Structure and Formation of Amyloids in Neurodegenerative Diseases With Chemical Biology Tools. Frontiers in Chemistry 10.
Crossref
Jiewen Wang, Guangbo Kang, Haibin Yuan, Xiaocang Cao, He Huang & Ario de Marco. (2022) Research Progress and Applications of Multivalent, Multispecific and Modified Nanobodies for Disease Treatment. Frontiers in Immunology 12.
Crossref
Eduardo Ruiz-López, Juan Calatayud-Pérez, Irene Castells-Yus, María José Gimeno-Peribáñez, Noelia Mendoza-Calvo, Miguel Ángel Morcillo & Alberto J. Schuhmacher. (2021) Diagnosis of Glioblastoma by Immuno-Positron Emission Tomography. Cancers 14:1, pages 74.
Crossref
Shiran Su, Thomas J. Esparza, Duong Nguyen, Simone Mastrogiacomo, Joong H. Kim & David L. Brody. (2021) Pharmacokinetics of Single Domain Antibodies and Conjugated Nanoparticles Using a Hybrid near Infrared Method. International Journal of Molecular Sciences 22:16, pages 8695.
Crossref
Eduardo Ruiz-López & Alberto J. Schuhmacher. (2021) Transportation of Single-Domain Antibodies through the Blood–Brain Barrier. Biomolecules 11:8, pages 1131.
Crossref
Nairo Brilhante-da-Silva, Rosa Maria de Oliveira Sousa, Andrelisse Arruda, Eliza Lima dos Santos, Anna Carolina Machado Marinho, Rodrigo Guerino Stabeli, Carla Freire Celedonio Fernandes & Soraya dos Santos Pereira. (2021) Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms. Molecular Diagnosis & Therapy 25:4, pages 439-456.
Crossref
Umma Habiba, Joseph Descallar, Fabian Kreilaus, Utpal K. Adhikari, Sachin Kumar, John W Morley, Bang V Bui, Maya Koronyo‐Hamaoui & Mourad Tayebi. (2021) Detection of retinal and blood Aβ oligomers with nanobodies. Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring 13:1.
Crossref
Elodie Pothin, Dominique Lesuisse & Pierre Lafaye. (2020) Brain Delivery of Single-Domain Antibodies: A Focus on VHH and VNAR. Pharmaceutics 12:10, pages 937.
Crossref
Eric Chabrol, Johann Stojko, Alexandre Nicolas, Thomas Botzanowski, Benjamin Fould, Mathias Antoine, Sarah Cianférani, Gilles Ferry & Jean A. Boutin. (2020) VHH characterization.Recombinant VHHs: Production, characterization and affinity. Analytical Biochemistry 589, pages 113491.
Crossref
Gezim Bala, Maxine Crauwels, Anneleen Blykers, Isabel Remory, Andrea L.J. Marschall, Stefan Dübel, Laurent Dumas, Alexis Broisat, Charlotte Martin, Steven Ballet, Bernard Cosyns, Vicky Caveliers, Nick Devoogdt, Catarina Xavier & Sophie Hernot. (2019) Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis – impact of radiochemistry on pharmacokinetics. Biological Chemistry 400:3, pages 323-332.
Crossref
Larissa Jank, Carolina Pinto-Espinoza, Yinghui Duan, Friedrich Koch-Nolte, Tim Magnus & Björn Rissiek. (2019) Current Approaches and Future Perspectives for Nanobodies in Stroke Diagnostic and Therapy. Antibodies 8:1, pages 5.
Crossref
Pierre Lafaye & Tengfei Li. (2018) Use of camel single-domain antibodies for the diagnosis and treatment of zoonotic diseases. Comparative Immunology, Microbiology and Infectious Diseases 60, pages 17-22.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.